The store will not work correctly when cookies are disabled.
1-(4-methoxyphenethyl)-5-phenyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
ID: ALA4289994
PubChem CID: 145989308
Max Phase: Preclinical
Molecular Formula: C20H22N4O
Molecular Weight: 334.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(CCn2nnc3c2CCN(c2ccccc2)C3)cc1
Standard InChI: InChI=1S/C20H22N4O/c1-25-18-9-7-16(8-10-18)11-14-24-20-12-13-23(15-19(20)21-22-24)17-5-3-2-4-6-17/h2-10H,11-15H2,1H3
Standard InChI Key: OAEQZCVOWIUECL-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
25.1366 -0.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6804 -0.6534 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4256 -1.4276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9681 -2.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7139 -2.8117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9136 -2.9786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3594 -2.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6211 -1.5945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6595 -3.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8618 -3.9259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6118 -4.7002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0939 -5.3646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6118 -6.0287 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8297 -5.7763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1196 -6.1889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4137 -5.7763 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4137 -4.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1196 -4.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8297 -4.9530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7042 -6.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9987 -5.7685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2892 -6.1729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2892 -6.9879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9885 -7.4044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7042 -7.0018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
4 3 2 0
5 4 1 0
6 5 2 0
6 7 1 0
8 7 2 0
3 8 1 0
6 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
15 14 1 0
16 15 1 0
16 17 1 0
18 17 1 0
19 18 1 0
14 19 2 0
11 19 1 0
20 16 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
20 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.42 | Molecular Weight (Monoisotopic): 334.1794 | AlogP: 3.09 | #Rotatable Bonds: 5 |
Polar Surface Area: 43.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.83 | CX LogP: 3.52 | CX LogD: 3.52 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -1.39 |
References
1. Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W.. (2018) Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents., 28 (21): [PMID:30286952] [10.1016/j.bmcl.2018.09.019] |